Choose timezone
Your profile timezone:
Hadron Therapy Workshop: status and perspectives, plans for next generation facilities 18-19 October 2024
→
Europe/Zurich
Zoom
Zoom
https://cern.zoom.us/j/66191778491?pwd=trGT2SYZAbOE5ZpaIwmzV5oA8UZbXQ.1
Description
Webcast Link: https://webcast.cern.ch/view/wyxgrrnoendlmwbp/1431627
Scientific Assistants: Elpida Theodoridou (Uni Malta/DKFZ) chair, Nermine Muradi (Uni Tetova) chair, Alexandros Puckett Anastasiou (Uni Patra), Athanasios Athanasiou (AUTh), Christina Litou (AUTh), Dafni Giannakeri (AUTh), Effrosyni Chatzivasiloglou (AUTh), George Ntinas (AUTh), Maria Eleni Bozika (AUTh), Maria Vagianni (AUTh), Emina Huko (UNSA), Feriha Babic (UNSA), Naida Ustavdic (UNSA), Medina Dugonjic (UNSA), Danis Bradaric (UNSA).
Zoom Meeting ID
66191778491
Host
Elpida Theodoridou
Alternative hosts
John Cassar, Pascal Pignereau
Passcode
79297225
Useful links
Join via phone
Zoom URL
-
-
8:00 AM
→
11:30 AM
SESSION 1 - HADRON THERAPY OVERVIEW
Moderators: Manjit Dosanjh, Yiota Foka
-
8:00 AM
Participants registration 45m
-
8:45 AM
Welcome Addresses 30m
Maria Bigaki (IAEA CP, Papageorgiou), Michail Karaviotis ( Papageorgiou),
Sotirios Charisopoulos (IAEA), Sandro Rossi (HITRIplus, CNAO),
Panagiotis Bamidis (AUTH,/AHEPA, ELEVIT) -
9:15 AM
Historic and scientific evolution of Hadron Therapy 20mSpeakers: Ugo Amaldi (TERA Foundation (IT)), Sandro Rossi (CNAO)
- 9:35 AM
-
9:55 AM
Radiobiology of Hadron Therapy 20mSpeaker: Angelica Facoetti (CNAO)
-
10:15 AM
HITRIplus project, its impact on boosting research in South East Europe and future perspectives 20mSpeaker: Sanja Damjanovic (SEEIIST Association (CH) / GSI)
-
10:35 AM
Building capacity through the IAEA programs 20mSpeaker: Sotirios Charisopoulos (IAEA)
-
10:55 AM
Coffee Break 35m
-
8:00 AM
-
11:30 AM
→
3:00 PM
SESSION 2 – HADRON THERAPY DEVELOPMENTS AND FUTURE PERSPECTIVES
Moderator: Roberto Orecchia
-
11:30 AM
Hadron Therapy : from pioneering times towards the future 20mSpeaker: Manjit Dosanjh (University of Oxford (GB))
-
11:50 AM
SEEIIST facility design and alternatives 20mSpeaker: Maurizio Vretenar (CERN)
-
12:10 PM
CERN as an example of large scale infrastructure 20mSpeaker: Emmanuel Tsesmelis (CERN)
-
12:30 PM
Status and vision of the SEEIIST project 20mSpeaker: Leandar Litov (University of Sofia - St. Kliment Ohridski (BG))
-
12:50 PM
Concluding remarks 10mSpeaker: Roberto Orecchia (IEO)
-
1:00 PM
Round table – SEEIIST towards to the Future 45m
Moderators: Sotirios Charisopoulos (IAEA), Sandro Rossi (HITRIplus, CNAO)
Panelists: Maurizio Vretenar (CERN), Semi Harrabi (HIT)
Contributions: Introduction, cancer incidence in SEE Mimoza Ristova (Uni Skopje) -
1:45 PM
Lunch Break 1h 15m
-
11:30 AM
-
3:00 PM
→
5:00 PM
SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE
Moderator: Angelica Facoetti
-
3:00 PM
Hadron Therapy at GSI - where we come from, where we go 25mSpeaker: Konrad Lehmann (GSI)
-
3:25 PM
The HIT facility, technology, clinical applications and research: novel approaches in particle therapy 25mSpeaker: Andrea Mairani (HIT)
-
3:50 PM
The Krakow Hadron Therapy facility, lessons learnt 25mSpeaker: Pawel Olko (IFJ - PAN)
-
4:15 PM
Concluding remarks 15mSpeaker: Angelica Facoetti (CNAO)
-
4:30 PM
Coffee Break 30m
-
3:00 PM
-
5:00 PM
→
10:20 PM
SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES
Moderator: Laura Vallow
-
5:00 PM
Accelerator and beam physics developments for medical and societal applications at CERN 20mSpeaker: Alessandra Lombardi (CERN)
-
5:20 PM
Innovative gantry designs: Superconducting magnets for advanced gantry 15mSpeaker: Ernesto De Matteis (INFN)
-
5:35 PM
Innovative gantry designs-continued 15mSpeaker: Ariel Haziot (CERN)
-
5:50 PM
Optimisation for pre-injectors for hadron therapy-AM 20mSpeaker: Aristeidis Mamaras (Aristotle University of Thessaloniki / CERN)
-
6:10 PM
An ion source project as a seed to build capacity for next generation accelerator physicists in Bosnia-and-Herzegovina 15mSpeakers: Amer Ajanovic (CERN/UNSA), Danis Bradaric (UNSA), Medina Dugonjic (UNSA), Naida Ustavdic (UNSA)
-
6:25 PM
Development of the first table-top X-ray FLASH system 15mSpeakers: Ms ELPIDA THEODORIDOU (DKFZ / Uni Malta), Joao Seco (DKFZ)
-
6:40 PM
Concluding remarks 5mSpeaker: Laura Vallow (Mayo Clinic)
- 8:00 PM
-
5:00 PM
-
8:00 AM
→
11:30 AM
-
-
9:00 AM
→
11:30 AM
Session 5 – INDICATIONS FOR HADRON THERAPY: Indications and clinical applications of HT at the Marburg facility
Moderators: Arnold Pompos, Joao Seco
-
9:00 AM
Chordoma treatments at CNAO 25mSpeaker: Maria Rosaria Fiore (CNAO)
-
9:25 AM
Sarcoma treatments in Greece 20mSpeaker: Tasos Kyriazoglou (Attikon University Hospital)
-
9:45 AM
Radiosurgery for Skullbase Meningiom 20mSpeaker: Christos Boskos (ST. LUKE'S)
-
10:05 AM
SRS Treatment Planning for Endocranial Tumor 20mSpeaker: Anna Makridou
-
10:25 AM
Personalization of hadron therapy for radioresistant cancers through bioindicators of radioresistance or conditional vulnerability 25mSpeaker: Michael Story (Mayo Clinic)
-
10:50 AM
Concluding remarks 10mSpeakers: Arnold Pompos (UT Southwestern, Dallas, TX), Joao Seco (DKFZ)
-
11:05 AM
Coffee Break 25m
-
9:00 AM
-
11:30 AM
→
3:00 PM
SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPYConvener: Sandro Rossi (Fondazione CNAO)
-
11:30 AM
Hadrontherapy and EU clinical networks: status and perspectives 20mSpeaker: Lisa Licitra (CNAO, Uni Milan)
-
11:50 AM
Costs of hadrontherapy, the ABC analysis applied to operations in CNAO 20mSpeaker: Maria Vittoria Livraga (CNAO)
-
12:10 PM
Caring for cancer patients: the CNAO social approach 20mSpeaker: Silvia Meneghello (CNAO)
-
12:30 PM
The role of citizens in innovating health 15mSpeakers: Katerina Zourou (Web2Learn), Stefania Oikonomou (Web2Learn)
-
12:45 PM
The role of biomedical and clinical engineering societies in advancing and promoting Hadron Therapy on a national and international level 15mSpeaker: Alkinoos Athanasiou (AUTH, ELEVIT)
-
1:00 PM
Challenges and Opportunities in the Patient's Pathway to Access 20mSpeaker: Menia Koukougianni (NGO KARKINAKI)
-
1:20 PM
Empowering patient advocacy and cancer prevention 15mSpeaker: Panagiotis Bamidis (AUTH/AHEPA, ELEVIT)
-
1:35 PM
Concluding remarks 5mSpeaker: Sandro Rossi (CNAO)
-
1:40 PM
Lunch Break 1h 20m
-
11:30 AM
-
3:00 PM
→
6:45 PM
SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY
Moderators: Antonio Capizzello, Emmanouel Chatzipantelis, Eugenia Papakonstantinou, Semi Harrabi
-
3:00 PM
Carbon Programme in MedAustron 15mSpeaker: Piero Fossati (MedAustron)
-
3:15 PM
Pediatric Treatments in MedAustron 15mSpeaker: Carola Lütgendorf-Caucig (MedAustron)
-
3:30 PM
Hadron therapy state-of-the art in pediatric oncology-clinical aspects 15mSpeaker: Sabina Vennarini (CNAO)
-
3:45 PM
Treatment planning for pediatric cancer tumour treatments 15mSpeaker: Alfredo Mirandola (CNAO)
-
4:00 PM
Pediatric brain tumour surgery : where do we stand? 15mSpeaker: Nikos Foroglou (AUTH/AHEPA)
-
4:15 PM
Role of surgery in pediatric soft tissue sarcoma 15mSpeaker: Aikaterini Tzantzaroudi (Hippokration Hospital)
-
4:30 PM
Coffee Break 30m
-
5:00 PM
Panel discussion: Paediatric Oncology in Greece 1h 30m
-
5:01 PM
Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit University Hospital AHEPA 15mSpeaker: Emmanouel Chatzipantelis (AUTH/AHEPA)
-
5:15 PM
Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit Hospital Hippoktateio Hospital 15mSpeaker: Evgenia Papakonstantinou (Hippokrateio Hospital)
-
5:30 PM
Pediatric patients commonly referred for external beam Radiotherapy 15mSpeakers: Antonio Capizzello (AUTH / AHEPA), Eftychia Tataridou (Theageneio Hospital)
-
5:45 PM
The spectrum of pediatric patients referred for Protontherapy 15mSpeaker: Barbara Rombi (APSS - TRENTO)
-
6:00 PM
Radiation treatment plan for pediatric cancer: a clinical view 15mSpeaker: George Giakoumetis (AUTH/AHEPA)
-
6:15 PM
Concluding remarks 15mSpeaker: Semi Harrabi (HIT)
-
3:00 PM
-
9:00 AM
→
11:30 AM
